Answers are grounded in this paper and cite their sources.
Diabetes mellitus is a chronic disorder characterized by persistent hyperglycemia that damages multiple organs. With global prevalence rising, accurate, convenient, and non-invasive glucose monitoring is urgently needed. However, current diagnostic methods—such as point-sample tests and continuous glucose monitoring (CGM)—remain limited by invasiveness and potential inaccuracy. In this study, we conduct an in vitro feasibility evaluation toward non-invasive glucose monitoring using an 80 MHz high-frequency ultrasound (HFU) transducer paired with a convolutional neural network (CNN). Signals were converted into time-frequency representations and analyzed using CNNs to classify blood samples by glucose concentration. Despite the inherent heterogeneity and noise in whole blood, the system achieved approximately 68% multi-class accuracy across glucose levels. These results indicate that ultrasound-based, AI-driven signal analysis offers a promising alternative for continuous, non-invasive glucose assessment, supporting improved diabetes management in clinical and home settings.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: